HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mário L R Monteiro Selected Research

PPAR gamma

9/2003Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mário L R Monteiro Research Topics

Disease

8Ganglion Cysts (Ganglion)
01/2022 - 12/2013
5Hemianopsia (Bitemporal Hemianopsia)
01/2022 - 08/2009
4Optic Nerve Diseases (Optic Neuropathy)
01/2022 - 06/2008
3Multiple Sclerosis
12/2022 - 06/2012
3Neuromyelitis Optica (Devic's Disease)
12/2022 - 06/2012
3Optic Neuritis (Retrobulbar Neuritis)
12/2022 - 02/2011
3Graves Ophthalmopathy
01/2022 - 09/2003
3Atrophy
01/2020 - 04/2008
2Papilledema
07/2022 - 06/2015
2Cognitive Dysfunction
12/2019 - 01/2016
2Pituitary Neoplasms (Pituitary Adenoma)
01/2017 - 08/2010
2Neoplasms (Cancer)
05/2012 - 09/2006
1Weight Loss (Weight Reduction)
07/2022
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
07/2022
1Exophthalmos (Proptosis)
01/2022
1Glaucoma
01/2022
1Polypoidal Choroidal Vasculopathy
11/2021
1Mydriasis
01/2018
1Hemorrhage
08/2015
1Macular Edema
02/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
02/2015
1Retinal Diseases
07/2014
1Retinal Neovascularization
11/2012
1Transverse Myelitis (Necrotizing Myelitis)
02/2011
1Optic Atrophy
08/2010
1Rupture
04/2010
1Cataract (Cataracts)
04/2010
1Capsule Opacification
04/2010
1Enophthalmos
07/2005

Drug/Important Bio-Agent (IBA)

18Retinaldehyde (Retinal)IBA
12/2022 - 04/2008
3Bevacizumab (Avastin)FDA Link
11/2021 - 11/2012
2Acetazolamide (Diamox)FDA LinkGeneric
07/2022 - 11/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2014 - 11/2012
1Proteins (Proteins, Gene)FDA Link
12/2022
1Biomarkers (Surrogate Marker)IBA
12/2022
1Myelin-Oligodendrocyte GlycoproteinIBA
12/2022
1LipidsIBA
11/2021
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2018
1Ranibizumab (Lucentis)FDA Link
02/2015
1GadoliniumIBA
05/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2011
1Trypan BlueFDA Link
04/2010
1Indicators and Reagents (Reagents)IBA
06/2008
1PPAR gammaIBA
09/2003

Therapy/Procedure

3Decompression
01/2022 - 01/2011
2Aftercare (After-Treatment)
01/2011 - 08/2010
2Drug Therapy (Chemotherapy)
09/2006 - 07/2005
1Intravitreal Injections
11/2021
1Vitreoretinal Surgery
01/2018
1Vitrectomy
01/2018
1Light Coagulation
02/2015
1Craniotomy
05/2012
1Lasers (Laser)
04/2008
1Radiotherapy
09/2006